title: Neuromyelitis optica with very late onset.
authors.forename: Romain
authors.initials: R
authors.lastname: Lefaucheur
authors.forename: Bertrand
authors.initials: B
authors.lastname: Bourre
authors.forename: Patrick
authors.initials: P
authors.lastname: Ahtoy
authors.forename: Ozlem
authors.initials: O
authors.lastname: Ozkul
authors.forename: Eléonore
authors.initials: E
authors.lastname: Tollard
authors.forename: Didier
authors.initials: D
authors.lastname: Hannequin
authors.forename: David
authors.initials: D
authors.lastname: Maltête
mesh_terms: D017668:Age of Onset; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005074:Evoked Potentials, Visual / Q000187:drug effects / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D009460:Neurologic Examination; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology; D013904:Thoracic Vertebrae / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone